ARTICLE | Clinical News
Cysteamine: Phase IIa started
September 29, 2014 7:00 AM UTC
NovaBiotics began an open-label, U.K. Phase IIa trial to evaluate oral Lynovex in about 12 patients with CF. The product has Orphan Drug designation in the U.S. and EU to treat CF. ...